期刊文献+

新型隐球菌性脑膜炎临床特点分析与脑脊液Th1-Th2细胞因子检测 被引量:5

Clinical characteristics and expression of Th1-Th2 cytokines in the cerebrospinal fluid of patients with cryptococcal meningitis
下载PDF
导出
摘要 研究背景新型隐球菌性脑膜炎是新型隐球菌感染脑膜和(或)脑实质引起的中枢神经系统感染性疾病,其发生、发展和转归在一定程度上取决于患者自身免疫功能,尤其与辅助性T细胞亚群Th1/Th2免疫应答失衡有关。本研究旨在探讨新型隐球菌性脑膜炎患者中枢神经系统局部Th1和Th2免疫应答作用。方法采用酶联免疫吸附试验定量检测脑脊液Th1细胞因子[干扰素-γ(IFN-γ)、肿瘤坏死因子-α(TNF-α)]和Th2细胞因子[白细胞介素-10(IL-10)]水平,并动态监测脑脊液细胞学变化。结果脑膜炎组患者脑脊液Th1细胞因子IFN-γ、TNF-α为(11.17±1.50)和(18.74±2.97)pg/ml,低于对照组的(17.69±2.34)和(28.83±3.55)pg/ml(均P=0.000),Th2细胞因子IL-10为(43.65±10.12)pg/ml,高于对照组的(7.80±1.30)pg/ml(P=0.000);急性期IFN-γ、TNF-α为(11.17±1.50)和(18.74±2.97)pg/ml,低于稳定期的(17.70±2.34)和(22.93±1.53)pg/ml(均P=0.000),IL-10为(43.65±10.12)pg/ml,高于稳定期的(22.93±7.39)pg/ml(P=0.000)。脑膜炎组患者脑脊液IFN-γ/IL-10、TNF-α/IL-10比值低于对照组(均P=0.000),急性期亦低于稳定期(均P=0.000)。结论 Th2免疫应答模式在新型隐球菌性脑膜炎急性期起重要作用,至稳定期转变为以Th1为主的免疫反应。提示Th1/Th2免疫应答失衡与新型隐球菌性脑膜炎发病机制密切相关。 Background Cryptococcal meningitis (CM) is the most common fungal infection of central nervous system,caused by Cryptococcus neoformans infection of the meninges.The development and prognosis of CM depend on the patient's own immune function to some extent,and are relative to the imbalance of helper T lymphocyte (Th1/Th2).This study aims to explore the hidden role of the local Th1/Th2 immune response in the pathophysiological process of CM.Methods The levels of Th1 cytokines interferon-γ (IFN-γ),tumor necrosis factor-α (TNF-α) and Th2 cytokine interleukin-10 (IL-10) in the cerebrospinal fluid (CSF) were detected by enzyme-linked immunosorbent assay (ELISA).CSF cytology changes were monitored dynamically to understand the outcome status of patients with CM.Results The levels of IFN-γ and TNF-α in CM patients [(11.17 + 1.50) and (18.74 + 2.97) pg/ml,respectively] were significantly lower than that in control patients [(17.69 + 2.34) and (28.83 ± 3.55) pg/ml; P=0.000,for all].However,the levels of IL-10 in CM patients [(43.65 ± 10.12) pg/ml] were significantly higher than that in control patients [(7.80 ± 1.30)pg/ml,P=0.000].The CSF IFN-γ and TNF-α levels in acute phase of CM patients [(11.17 ± 1.50) pg/ml and (18.74 ± 2.97) pg/ml,respectively] were significantly lower than that in stable phase of CM patients [(17.70 ± 2.34) and (22.93 ± 1.53) pg/ml; P =0.000,for all].On the other hand,the levels of IL-10 were significantly higher in the acute phase than that in stable phase [(43.65 ± 10.12)and (22.93 + 7.39) pg/ml,respectively; P=0.000].The ratios of Thl/Th2 were used to assess the contribution of Th1/Th2 immunity in acute and stable phase of CM patients.The ratios of IFN-γ/IL-10 and TNF-α/IL-10 measured in acute phase of CM patients were significantly lower than that in control patients (P =0.000,for all).These ratios in acute phase patients were also significantly lower than that in stable phase patients (P=0.000,for all).Conclusions In acute phase,the Th2 response is dominant in patients with CM.However,the immune response shifts towards to Thl response in the stable phase,providing direct evidence that the imbalance of Th1-Th2 cytokines is related to the pathogenesis of CM.
出处 《中国现代神经疾病杂志》 CAS 2014年第8期680-686,共7页 Chinese Journal of Contemporary Neurology and Neurosurgery
关键词 脑膜炎 隐球菌性 脑脊髓液 T淋巴细胞 辅助诱导 干扰素Ⅱ型 肿瘤坏死因子α 白细胞介素10 Meningitis, cryptococcal Cerebrospinal fluid T-lymphocytes, helper-inducer Interferon type Ⅱ Tumor necrosis factor-alpha Interleukin-10
  • 相关文献

参考文献23

  • 1Li SS,Mody CH.Cryptococcus.Proc Am Thorac Soc,2010,7:186-196.
  • 2Wilder JA,Olson GK,Chang YC,Kwon-Chung KJ,Lipscomb MF.Complementation of a capsule deficient Cryptococcus neoformans with CAP64 restores virulence in a murine lung infection.Am J Respir Cell Mol Biol,2002,26:306-314.
  • 3Noverr MC,Williamson PR,Fajardo RS,Huffnagle GB.CNLAC1 is required for extrapulmonary dissemination of Cryptococcus neoformans but not pulmonary persistence.Infect Immun,2004,72:1693-1699.
  • 4Olszewski MA,Noverr MC,Chen GH,Toews GB,Cox GM,Perfect JR,Huffnagle GB.Urease expression by Cryptococcus neoformans promotes microvascular sequestration,thereby enhancing central nervous system invasion.Am J Pathol,2004,164:1761-1771.
  • 5Wormley FL Jr,Perfect JR,Steele C,Cox GM.Protection against cryptococcosis using a murine gamma interferon-producing Cryptococcus neoformans strain.Infect Immun,2007,75:1453-1462.
  • 6Wormley FL Jr,Cox GM,Perfect JR.Evaluation of host immune responses to pulmonary Cryptococcosis using a temperature-sensitive Cryptococcus neoformans calcineurin A mutant strain.Microb Pathog,2005,38(2/3):113-123.
  • 7Fox A,Jeffries DJ,Hill PC,Hammond AS,Lugos MD,Jackson-Sillah D,Donkor SA,Owiafe PK,McAdam KP,Brookes RH.ESAT-6 and CFP-10 can be combined to reduce the cost of testing for Mycobacterium tuberculosis infection,but·CFP-10 responses associate with active disease.Trans R Soc Trop Med Hyg,2007,101:691-698.
  • 8Galanis E,Macdougall L,Kidd S,Morshed M;British Columbia Cryptococcus gattii Working Group.Epidemiology of Cryptococcus gattii,British Columbia,Canada,1999-2007.Emerg Infect Dis,2010,16:251-257.
  • 9Chuang YM,Ho YC,Chang HT,Yu CJ,Yang PC,Hsueh PR.Disseminated cryptococcosis in HIV-uninfected patients.Eur J Clin Microbiol Infect Dis,2008,27:307-310.
  • 10王晓光,徐启桓.新型隐球菌性脑膜炎65例临床分析[J].中国实用内科杂志,2004,24(5):310-310. 被引量:11

二级参考文献8

共引文献34

同被引文献64

引证文献5

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部